Stifel Raises Hinge Health (HNGE) PT to $66 on Strong Business Momentum, Product Innovation

Hinge Health Inc. (NYSE:HNGE) is one of the best new stocks to buy right now. On September 11, Stifel analyst David Grossman raised the firm’s price target on Hinge Health to $66 from $63, while keeping a Buy rating on the shares. The firm believes that there is significant momentum behind Hinge’s business. In Q2 2025, Hinge Health reported a 55% year-over-year increase in revenue, which reached $139 million.

The company has significantly expanded its network and now has over 50 partners, which include the 5 largest national health plans and the top 3 PBMs. Hinge Health has launched several innovative products to maintain its leadership position. This includes AI-powered motion tracking technology and Hinge Select, which is a high-performance provider network.

Stifel Raises Hinge Health (HNGE) PT to $66 on Strong Business Momentum, Product Innovation

The company reported strong client retention rates and a record high member Net Promoter Score/NPS in H1 of the year, driven by a delightful product experience. The CFO noted that by the end of Q2, ~40% of clients had transitioned to a new pay-as-you-go pricing model that includes an upfront platform fee, which holds the company accountable for delivering engaging products and is expected to allow for future increases in Average Selling Price/ASP as record engagement continues.

Hinge Health Inc. (NYSE:HNGE) develops health care software for joint and muscle health. The company designs its platform to address musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.